Clinical trial No longer in our active list Interventional Ages 30 to 65

Exploring a fasting diet for Asian Americans with prediabetes

Official title: Pilot Study on Fasting-Mimicking Diet in Asian Americans with Prediabetes

Run by University of California, Irvine · NCT06518798 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing a special fasting diet for Asian Americans with prediabetes to see if it helps improve their blood sugar levels and if people can stick with it.

Quick facts

Study typeInterventional
Ages30 Years to 65 Years
SexAll
Enrollment30 (estimated)
SponsorUniversity of California, Irvine
Academic / other
Locations1 site (Irvine, California)
Trial IDNCT06518798 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Asian Americans diagnosed with prediabetes based on specific blood glucose criteria.

Probably not a fit

Patients with a history of diabetes, cardiovascular disease, or certain dietary restrictions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study investigates the feasibility of implementing a Fasting-Mimicking Diet (FMD) specifically tailored for Asian Americans diagnosed with prediabetes. Participants will follow a calorie-restricted nutrition regimen over a 5-day period, and the study aims to assess recruitment, adherence, and attrition rates, as well as the diet's effects on fasting blood glucose levels and physical measurements. Participants will undergo pre- and post-diet evaluations, including surveys and blood tests to measure glucose and ketone levels.

Why it matters

Potential benefit: If successful, this approach could provide an effective dietary intervention to help manage prediabetes in Asian American populations.

How similar studies have gone: While the Fasting-Mimicking Diet is a novel approach, similar dietary interventions have shown promise in managing metabolic conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

* Identify as Asian American
* Diagnosed with prediabetes according to at least one of the following:
* HbA1C 5.7%-6.4%
* Fasting blood glucose 100 to 125 mg/dL (5.6 to 6.9 mmol/L )
* Oral glucose tolerance test (OGTT) 140-199 mg/dL at two hours

Exclusion criteria:

* Individuals with a personal history of diabetes mellitus (ICD-10 codes E08-E13), cardiovascular disease, mental illness, drug dependency, pregnancy, and special dietary restrictions
* Individuals taking insulin or insulin-like drugs and individuals taking hypoglycemic agents other than metformin
* Individuals who are pregnant or breastfeeding
* Individuals with anaphylaxis food allergies
* Individuals who are allergic to tree nuts (macadamia, cashew, almond, pecan), soy, oats, sesame, or celery/celeriac
* Individuals who have completed the FMD in the past year

Where it's running

  • UC Irvine
    Irvine, California, United States
    Recruiting

Study contacts

  • Principal investigator: Hannah Lui Park, PhD — University of California, Irvine
  • Study coordinator: Mirian Kang
  • Email: miriank@uci.edu
  • Phone: 714-750-6536

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.